HAEMONETICS CORP — Director's Dealing 2015

Mar 5, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2015-03-04

Reporting Person: MERRIMAN RONALD (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-03-04	Common Stock	M	2500.0	$27.24	Acquired	14605	Direct
2015-03-04	Common Stock	S	2500.0	$43.7984	Disposed	12105	Direct
2015-03-04	Common Stock	M	11758.0	$29.72	Acquired	23863	Direct
2015-03-04	Common Stock	S	11758.0	$43.7984	Disposed	12105	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-03-04	Non-Qualified Stock Option (right to buy)	$27.24	M	2500.0	Disposed	2017-07-29	Common Stock (2500)	Direct
2015-03-04	Non-Qualified Stock Option (right to buy)	$29.72	M	11758.0	Disposed	2016-07-30	Common Stock (11758)	Direct

Footnotes

F1: Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.